|
| 37543235 | A Dosimetric Correlation Between Radiation Dose to Bone and Reduction of Hemoglobin Levels After Radiation Therapy for Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2024 |
| 36179990 | External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 37856213 | Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 |
| 37722084 | Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. | JCO Oncol Pract | 2023 |
| 37082724 | Successful Salvage Brachytherapy after Infusion of Gold AuroShell Nanoshells for Localized Prostate Cancer in a Human Patient. | Adv Radiat Oncol | 2023 |
| 36812123 | Secondary malignancies in non-Hodgkin lymphoma survivors: 40â¿¿years of follow-up assessed by treatment modality. | Cancer Med | 2023 |
| 36526395 | In Regard to Dess. | Int J Radiat Oncol Biol Phys | 2023 |
| 34291289 | Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report. | J Natl Cancer Inst | 2022 |
| 35787979 | The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. | Clin Genitourin Cancer | 2022 |
| 35554777 | Factors associated with changes in exercise behaviors during the COVID-19 pandemic. | Cancer Causes Control | 2022 |
| 36509074 | NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. | J Natl Compr Canc Netw | 2022 |
| 36420188 | Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. | Adv Radiat Oncol | 2022 |
| 35948037 | NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022. | J Natl Compr Canc Netw | 2022 |
| 35243690 | Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. | J Rural Health | 2022 |
| 35304077 | Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT. | Clin Genitourin Cancer | 2022 |
| 35084098 | Technical note: Evaluation of a silicone-based custom bolus for radiation therapy of a superficial pelvic tumor. | J Appl Clin Med Phys | 2022 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 33909949 | Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration. | BJU Int | 2021 |
| 33545689 | NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 33731274 | The Stage at Presentation and Oncologic Outcomes for Agent Orange Exposed and Non-Exposed United States Veterans Diagnosed With Prostate Cancer. | Clin Genitourin Cancer | 2021 |
| 33608228 | Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy. | Clin Genitourin Cancer | 2021 |
| 33858789 | Stage Presentation, Care Patterns, Treatment Outcomes, and Impact of Radiotherapy on Overall Survival for Adrenocortical Carcinoma. | Clin Genitourin Cancer | 2021 |
| 35128177 | Radiation Therapy in Conjunction With Surgical Stabilization of Impending or Pathologic Fractures Secondary to Metastasis: Is There a Difference Between Single and Multifraction Regimens? | Adv Radiat Oncol | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 34580667 | Impact of the COVID-19 pandemic on exercise habits among cancer patients. | Res Sq | 2021 |
| 34250421 | Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion. | JCO Precis Oncol | 2021 |
| 34130915 | Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative Patients. | Clin Genitourin Cancer | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 34337486 | Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate. | Eur Urol Open Sci | 2021 |
| 31243337 | Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy. | Prostate Cancer Prostatic Dis | 2020 |
| 32928598 | Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize Therapy. | Int J Radiat Oncol Biol Phys | 2020 |
| 33020930 | Comparison of transperineal ultrasound image guidance technique to transabdominal technique for prostate radiation therapy. | Med Phys | 2020 |
| 32335061 | Definitive Chemoradiotherapy for Locally Advanced, Lymph-node Positive, Nonmetastatic Penile Squamous Cell Carcinoma. | Clin Genitourin Cancer | 2020 |
| 32335059 | Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy. | Clin Genitourin Cancer | 2020 |
| 32464368 | <sup>18</sup>F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE. | Pract Radiat Oncol | 2020 |
| 32135513 | Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2020 |
| 32395350 | Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients. | Prostate Cancer | 2020 |
| 31085757 | Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2019 |
| 31355998 | Calculation of delivered composite dose from Calypso tracking data for prostate cancer: And subsequent evaluation of reasonable treatment interruption tolerance limits. | J Appl Clin Med Phys | 2019 |
| 31294753 | Germline Variants in Highly Selected Patients With Prostate Cancer. | JAMA Oncol | 2019 |
| 28621623 | Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database. | J Neurosurg | 2018 |
| 30181416 | NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. | J Natl Compr Canc Netw | 2018 |
| 29904742 | Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database. | Adv Radiat Oncol | 2018 |
| 29950592 | The case for nonsurgical therapy of nonmetastatic penile cancer. | Nat Rev Urol | 2018 |
| 30603117 | Daily breathing inconsistency in pancreas SBRT: a 4DCT study. | J Gastrointest Oncol | 2018 |
| 30453392 | Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. | Cancer Med | 2018 |
| 29655620 | Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance. | Urol Oncol | 2018 |
| 27469289 | Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer. | BJU Int | 2017 |
| 28274407 | Comparison of 2 transabdominal ultrasound image guidance techniques for prostate and prostatic fossa radiation therapy. | Pract Radiat Oncol | 2017 |